Clinical Trial Update: Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing an alternative antiandrogen therapy with early initiation of enzalutamide in castration-resistant prostate cancer after prior combined a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Alternative Antiandrogen (AA) Therapy (unknown)
• Enzalutamide (enzalutamide)

Snippet

Sponsor: Taro Iguchi, MD, PHD | Conditions: Castration-resistant Prostate Cancer | Phase 2 | Status: COMPLETED